Lista de obras - Joseph Arturo Pinto - Dominio Público Uruguay

A prognostic signature based on three-genes expression in triple-negative breast tumours with residual disease.

artículo científico publicado en 2016

ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer

artículo científico publicado en 2019

Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma: a phase II trial showing reduction in toxicity without altering long-term survival.

artículo científico publicado en 2012

Automated segmentation and classification of cell nuclei in immunohistochemical breast cancer images with estrogen receptor marker.

artículo científico publicado en 2016

Barriers in Latin America for the management of locally advanced breast cancer

scientific article published on 22 January 2019

Breast cancer classification according to immunohistochemistry markers: subtypes and association with clinicopathologic variables in a peruvian hospital database.

artículo científico publicado en 2010

Clinical consequences of resistance to ALK inhibitors in non-small cell lung cancer

scientific article published on 29 January 2020

Control of cervical cancer in Peru: Current barriers and challenges for the future.

scientific article published on 10 June 2016

Current knowledge of Ipilimumab and its use in treating non-small cell lung cancer

scientific article published on 29 April 2019

DNA Damage Inducible Transcript 4 Gene: The Switch of the Metabolism as Potential Target in Cancer

artículo científico publicado en 2018

EGFR-RAD51 Fusion: A Targetable Partnership Originated from the Tumor Evolution?

artículo científico publicado en 2018

Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer.

artículo científico publicado en 2018

Epidemiologic Patterns of COVID-19 Incidence in the Province of Lima

artículo científico publicado en 2020

From colorectal cancer pattern to the characterization of individuals at risk: picture for genetic research in Latin America

article

H-scan analysis of thyroid lesions.

artículo científico publicado en 2018

Helicobacter pylori: History and facts in Peru

scientific article published on 19 December 2018

High Epidermal Growth Factor Receptor Mutation Rates in Peruvian Patients With Non-Small-Cell Lung Cancer: Is It a Matter of Asian Ancestry?

artículo científico publicado en 2017

History of the development of radiotherapy in Latin America

artículo científico publicado en 2017

In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies.

artículo científico publicado en 2017

Lactate Dehydrogenase B: A Metabolic Marker of Response to Neoadjuvant Chemotherapy in Breast Cancer ⬇️

artículo científico publicado el 22 de mayo de 2013

Lung Cancer in the Young

scientific article published on 26 November 2019

Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy

artículo científico publicado en 2020

Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets

artículo científico publicado en 2013

Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer.

artículo científico publicado en 2017

Old myths about old patients: the case of non-small cell lung cancer

artículo científico publicado en 2018

PIK3CA mutations in Peruvian patients with HER2-amplified and triple negative non-metastatic breast cancers.

artículo científico publicado en 2014

Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer

scientific article published on 09 August 2019

Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America

artículo científico publicado en 2019

Primary and metastatic brain cancer genomics and emerging biomarkers for immunomodulatory cancer treatment.

artículo científico publicado en 2018

Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance

artículo científico publicado en 2012

Repeated observation of immune gene sets enrichment in women with non-small cell lung cancer.

artículo científico publicado en 2016

Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence.

artículo científico publicado en 2016

[Optimal cytoreduction in advanced ovarian cancer treated with dose-dense paclitaxel and carboplatin followed by interval surgery at the Peruvian National Institute of Neoplastic Diseases]

artículo científico publicado en 2018

Lista de obras de Joseph Arturo Pinto

A prognostic signature based on three-genes expression in triple-negative breast tumours with residual disease.

ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer

Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma: a phase II trial showing reduction in toxicity without altering long-term survival.

Automated segmentation and classification of cell nuclei in immunohistochemical breast cancer images with estrogen receptor marker.

Barriers in Latin America for the management of locally advanced breast cancer

Breast cancer classification according to immunohistochemistry markers: subtypes and association with clinicopathologic variables in a peruvian hospital database.

Clinical consequences of resistance to ALK inhibitors in non-small cell lung cancer

Control of cervical cancer in Peru: Current barriers and challenges for the future.

Current knowledge of Ipilimumab and its use in treating non-small cell lung cancer

DNA Damage Inducible Transcript 4 Gene: The Switch of the Metabolism as Potential Target in Cancer

EGFR-RAD51 Fusion: A Targetable Partnership Originated from the Tumor Evolution?

Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer.

Epidemiologic Patterns of COVID-19 Incidence in the Province of Lima

From colorectal cancer pattern to the characterization of individuals at risk: picture for genetic research in Latin America

H-scan analysis of thyroid lesions.

Helicobacter pylori: History and facts in Peru

High Epidermal Growth Factor Receptor Mutation Rates in Peruvian Patients With Non-Small-Cell Lung Cancer: Is It a Matter of Asian Ancestry?

History of the development of radiotherapy in Latin America

In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies.

Lactate Dehydrogenase B: A Metabolic Marker of Response to Neoadjuvant Chemotherapy in Breast Cancer ⬇️

Lung Cancer in the Young

Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy

Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets

Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer.

Old myths about old patients: the case of non-small cell lung cancer

PIK3CA mutations in Peruvian patients with HER2-amplified and triple negative non-metastatic breast cancers.

Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer

Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America

Primary and metastatic brain cancer genomics and emerging biomarkers for immunomodulatory cancer treatment.

Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance

Repeated observation of immune gene sets enrichment in women with non-small cell lung cancer.

Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence.

[Optimal cytoreduction in advanced ovarian cancer treated with dose-dense paclitaxel and carboplatin followed by interval surgery at the Peruvian National Institute of Neoplastic Diseases]